The Big Market ReportToday's Briefing
S&P 500 & Equities·Bloomberg Markets· 3d ago

Compass Pathways CEO on Trump's Order to Expand Psychedelics Research

Strategic Analysis // Ian Gross

This executive order is a game-changer for the nascent psychedelic therapy industry, signaling a top-down push for research and potentially accelerating market adoption. It transforms the investment landscape from speculative to one with clearer regulatory tailwinds, making companies in this space suddenly more attractive. The key takeaway for investors is that government support can de-risk emerging sectors, and this is exactly what we're seeing here.

Human-Vetted Professional Intelligence
Market IntelligenceImpact: ★★★★☆

Why This Matters

  • ▸Presidential order boosts psychedelic therapy sector.
  • ▸Significant stock surges for companies like CMPS, ATAI.

Market Reaction

  • ▸Psychedelic-focused stocks saw immediate, sharp gains.
  • ▸Investor sentiment turned highly positive for the sector.

What Happens Next

  • ▸Watch for specific details on research funding and access.
  • ▸Monitor regulatory pathways for new drug approvals.

The Big Market Report Take

Alright, folks, this is big. President Trump just signed an executive order to expedite research and access for psychedelic therapies, and the market reacted exactly as you'd expect. Compass Pathways (CMPS) shares spiked an incredible 53%, while Atai Life Sciences (ATAI) wasn't far behind, surging 37%. GH Research (GHRS) also jumped 34%. This isn't just about a few companies; it's a significant signal that the U.S. government is serious about exploring these treatments, potentially opening up a massive new market. Expect continued volatility but also sustained interest in this nascent but rapidly growing sector.

Read full article on Bloomberg MarketsFollow on XFollow on BlueskyBack to today's briefing

Related Guides

Beginner

Stock Market Basics

What stocks are, how prices are set, valuation metrics, and how to start investing.

Risk

Market Volatility Guide 2026

What the VIX is telling you, how to read volatility signals, and strategies for navigating turbulent markets.

Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →

Never miss a story

More from this section